Related Experiment Videos
Multiple mechanisms of thrombosis complicating atherosclerotic plaques
1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Insights
Atherosclerosis, a common condition, involves plaque disruption and platelet activation. Combination antithrombotic therapies targeting platelets and coagulation may improve management of this leading cause of death.
Area of Science:
- Cardiovascular Biology
- Thrombosis Research
Background:
- Atherosclerosis is a widespread disease causing significant morbidity and mortality.
- Vascular biology advances illuminate atherogenesis mechanisms.
- Platelet activation and coagulation cascade are key in thrombotic events.
Purpose of the Study:
- To review the role of platelet activation and coagulation in atherosclerosis.
- To explore the potential of combination antithrombotic therapy.
Main Methods:
- Literature review of recent advances in vascular biology and thrombosis.
- Analysis of the role of platelets and coagulation in atherogenesis.
- Evaluation of therapeutic strategies targeting antithrombotic mechanisms.
Main Results:
- Plaque disruption initiates a cascade involving platelet adhesion, activation, and aggregation.
- Platelet activation triggers the coagulation cascade, contributing to thrombotic events.
- Understanding these mechanisms is crucial for managing atherosclerosis.
Conclusions:
- Combination antithrombotic therapy offers a promising approach.
- Targeting platelet activation and coagulation pathways may optimize atherosclerosis management.
Abstract:
Atherosclerosis is a highly prevalent disorder and remains a leading cause of morbidity and mortality in the United States. Recent advances in vascular biology have led to a better understanding of the mechanisms underlying atherogenesis. The central role played by plaque disruption, and by adhesion, activation, and aggregation of platelets that trigger activation of the coagulation cascade in the pathogenesis of acute thrombotic events is also better understood. Combination antithrombotic therapy targeting various platelet activation mechanisms and the coagulation cascade may help optimize the management of atherosclerosis.